The US confirms that it will allow the entry of those vaccinated with the doses approved by the WHO, including Sinopharm

USA will accept the entry of international visitors vaccinated with the doses authorized by US regulators or the World Health Organization (WHO), said a spokeswoman for the Centers for Disease Control and Prevention (CDC), Friday night , as reported by the Reuters agency.

On September 20, the White House announced that the United States in November would lift travel restrictions for travelers from 33 countries, including China, India, Brazil and most of Europe, who are fully vaccinated against the COVID-19. So it did not specify which vaccines would be accepted.

A CDC spokeswoman told Reuters on Friday: “Six vaccines that are either cleared by the FDA or listed for emergency use by the WHO meet the criteria for travel to the United States.” Thus, the Russian Sputnik vaccine, which is applied in some 70 countries, including Argentina, would be excluded from those accepted by the United States.

According to the announcement, those who have the complete schedule with any of the following vaccines will be able to enter the United States: Moderna, Pfizer, Janssen, Oxford/Astrazeneca, Sinopharm y Sinovac.

Late on Friday, the CDC said that “earlier this week, to help them prepare their systems, we informed the airlines” of the vaccines that would be accepted, adding that “the CDC will release additional guidance and information as they become available. travel requirements end ”.

Some countries had lobbied the Joe Biden administration to accept WHO-approved vaccines, as FDA-cleared vaccines are not widely used in all countries.

The new Covid-19 vaccine requirements will now apply to nearly all foreign nationals flying to the United States, including those who are not subject to the above restrictions.

The CDC must also spell out the rules for exceptions, which include children who are not yet eligible for vaccines.as well as visitors from countries where vaccines are not widely available. The administration must also decide whether to admit visitors as part of Covid-19 clinical trials or if they have recently contracted COVID-19 and are not yet eligible for vaccination.

_____________________